(RTTNews) - Retail sales in the U.S. increased by slightly more than expected in the month of February, the Commerce Department revealed in a report released on Wednesday.
(RTTNews) - Retail sales in the U.S. increased by slightly more than expected in the month of February, the Commerce Department revealed in a report released on Wednesday.
Smile Retail sales increased by 0.6% M/M in February to $738.4B, compared to a 0.1% decrease logged in the prior month (revised from -0.2%) and a +0.4% consensus, according to data released by the U.S. Census Bureau on Wednesday. Year-over-year, the headline number gained 3.7%. Retail trade sales were up 0.6% from January. Nonstore retailers advanced 7.5% from last year, while food service and dri...
Smile Retail sales increased by 0.6% M/M in February to $738.4B, compared to a 0.1% decrease logged in the prior month (revised from -0.2%) and a +0.4% consensus, according to data released by the U.S. Census Bureau on Wednesday. Year-over-year, the headline number gained 3.7%. Retail trade sales were up 0.6% from January. Nonstore retailers advanced 7.5% from last year, while food service and drinking places were up 5.2% on a yearly basis. Core retail sales (excluding motor vehicles and parts) jumped 0.5% M/M, vs. +0.3% consensus and 0.0% prior. Retail sales, excluding gas and autos, rose 0.4% from the previous month, compared to the +0.2% consensus and +0.2% prior. Total sales from December 2025 to February 2026 were up 3.1% from the same period a year ago. More on U.S. Economy Mortgage demand continues to fall amid rising rates Fed's Barr does not think government should back stablecoins Policymakers face trade-offs in pursuing Fed's dual mandate, says KC Fed's Schmid
Hinterhaus Productions/DigitalVision via Getty Images Based in the US, Schrödinger ( SDGR ) is one of the leading software companies in the scientific and biotechnology verticals, developing a computational platform to accelerate drug discovery and materials science. It mainly makes money through software licensing and collaborative drug discovery programs with major pharmaceutical companies. Comp...
Hinterhaus Productions/DigitalVision via Getty Images Based in the US, Schrödinger ( SDGR ) is one of the leading software companies in the scientific and biotechnology verticals, developing a computational platform to accelerate drug discovery and materials science. It mainly makes money through software licensing and collaborative drug discovery programs with major pharmaceutical companies. Companies like Certara ( CERT ), Simulation Plus, and Recursion Pharmaceuticals ( RXRX ) are some of the competitors in this space. Since its 2020 IPO, share performance has been underwhelming for the most part. SDGR plummeted from an all-time high of over $77 to recent lows of around $11, which is where it is more or less trading at. Sentiment has largely been negative, as SDGR is down almost -40% over the past year alone, driven mostly by the -36% decline in share prices YTD alone. I initiated my coverage on SDGR with a neutral rating. My 1-year price target of $10.6 per share projects a -6% decline YoY. My analysis found that SDGR remains hard to fairly value due to the transition in its software business model, which affects its revenue growth, suggesting that it is more prudent to stay on the sidelines for now. Financial Reviews In my opinion, fundamentals are a bit choppy, mainly due to the major business model transition from on-premise to a hosted software delivery model. Based on my experience covering software stocks, many similar transitions could indeed present a near-term volatility since they may produce some difficulties in fairly valuing the business, as I will touch on later in the valuation section. On the flip side, though, I think it is done for the benefit of more robust and visible long-term growth. Q4 presentation In Q4 2025, for instance, underlying growth remains solid, in my view, despite the reported Q4 top-line numbers appearing weak on the software side. SDGR saw a -13% quarterly revenue decline YoY in the software business due to revenue recognitio...
兰博基尼全球CEO称，对战略进行了一些调整，第四款车型将不会采用纯电模式，而是插电混动。 “我们对战略进行了一些调整，第四款车型将不会采用纯电模式，而是插电混动。”兰博基尼全球CEO Stephan Winkelmann近日对第一财经记者表示，未来将在电池技术方面持续投入，但第四款车型仍为插混。 Winkelmann认为，针对超豪华汽车市场纯电动车型接受度的调研结果显示，过去数年，全球市场对这类车...
(RTTNews) - Cannabis cultivator Tilray Brands, Inc. (TLRY, TLRY.TO) reported Wednesday a net loss attributable to stockholders of Tilray for the third quarter of $26.57 million or $0.24 per share, sharply narrower than a net loss of $789.86 million or $8.69 per share in the prior
(RTTNews) - Cannabis cultivator Tilray Brands, Inc. (TLRY, TLRY.TO) reported Wednesday a net loss attributable to stockholders of Tilray for the third quarter of $26.57 million or $0.24 per share, sharply narrower than a net loss of $789.86 million or $8.69 per share in the prior
Condor Energies ( CDR:CA ) on Wednesday announced the appointment of Matt Pachell as Chief Operating Officer from his previous position as the company’s Senior Vice President of Asset Development and Exploration. Pachell will oversee operations, project execution, and all technical functions to deliver Condor’s Central Asian growth strategies. Source: Press Release More on Condor Energies Financia...
Condor Energies ( CDR:CA ) on Wednesday announced the appointment of Matt Pachell as Chief Operating Officer from his previous position as the company’s Senior Vice President of Asset Development and Exploration. Pachell will oversee operations, project execution, and all technical functions to deliver Condor’s Central Asian growth strategies. Source: Press Release More on Condor Energies Financial information for Condor Energies
Futures, Bonds Surge On Optimism War May End, Oil Tumbles Below $100 Futures and bonds jump and oil fell, sending Brent briefly below $100 a barrel, as the de-escalation/technical/macro led relief rally continues on hopes of the Middle East conflict reaching an end soon after Donald Trump said he expects the war in Iran to end in two to three weeks, and indicated that it was possible that Iran cou...
Futures, Bonds Surge On Optimism War May End, Oil Tumbles Below $100 Futures and bonds jump and oil fell, sending Brent briefly below $100 a barrel, as the de-escalation/technical/macro led relief rally continues on hopes of the Middle East conflict reaching an end soon after Donald Trump said he expects the war in Iran to end in two to three weeks, and indicated that it was possible that Iran could still reach a deal with the US during that timeframe. Trump has a national address tonight at 9pm ET to discuss Iran, but the content is unclear, with the market is expressing the view that this will be details on a wind-down rather than an escalation. As of 8:15am ET, S&P Futures were 0.7% higher, after the cash index posted a near 3% advance on Tuesday, the best end to a quarter since September 2008 . Nasdaq futures jumped 1.1% with all Mag 7 names higher premarket. European stocks jumped 2.6%, alongside a 4.9% surge in Asian shares. Final Mfg PMIs from the Europe were mixed (EU, Germany, Italy small beats/UK, France small missed) while Japan/Korea Manf PMIs were slightly better. Trump is set to address the nation tonight at 9pm EST and said he expects the war to end in two to three weeks/US would withdraw once Tehran can no longer obtain nuclear weapons. Otherwise, the US is sending a third aircraft carrier to the region, Iran said the US “isn’t serious about diplomacy”, the WSJ reported that the UAE wants to force the Strait of Hormuz open and is willing to join the fight, and attacks continued on both sides with Qatar saying Iran struck an oil tanker. Brent fell 5.4% before paring the move as the Strait of Hormuz remained largely closed and attacks continued across the Gulf. Traders trimmed bets on tighter monetary policy, sending two-year Treasury yields three basis points lower to 3.76%. Comparable UK gilt yields dropped 10 basis points to 4.30%. Looking at today's US economic calendar, we get March ADP employment change (8:15am), February retail sales (8:30am), M...
The United States attacked Iran without consulting its European allies. President Donald Trump assumed the operation would be a quick win, over before anyone had to take a position. Instead, Washington answered a question Western governments had long avoided. After years of pushing Nato towards confrontation with China, would the transatlantic alliance fight a war it had not chosen together? The a...
The United States attacked Iran without consulting its European allies. President Donald Trump assumed the operation would be a quick win, over before anyone had to take a position. Instead, Washington answered a question Western governments had long avoided. After years of pushing Nato towards confrontation with China, would the transatlantic alliance fight a war it had not chosen together? The answer was no. Iran and Taiwan are different cases. One sits on Europe’s wider periphery and carries...